Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
163 words
A process for preparing an isoimmunogen for controlling biological action in an animal which comprises: activating a hormone endogenous to said animal, non-hormonal polypeptide endogenous to said animal or a synthetic or natural fragment of either having a sulfhydryl group thereon by treatment thereof with an activator of the structure ##STR16## where X represents a non-reacting group comprising substituted or unsubstituted phenyl or C 1-10 alkylene moieties, or a combination thereof, or an amino acid chain, so as to cause reaction of the maleiimide group of the activator with a said sulfhydryl group on said hormone, peptide or fragment and so as to minimize reaction of the active ester group with any amino group present on said hormone, peptide or fragment; and treating the resulting activated hormone, peptide or fragment at slightly alkaline pH with a carrier moiety biologically foreign to said animal and selected having a size sufficient to elicit antibody response following the administration thereof into the body of said animal.
Claim 2
Dependent Claim
163 words
A process for preparing an isoimmunogen for controlling biological action in an animal which comprises: activating a hormone endogenous to said animal, non-hormonal polypeptide endogenous to said animal or a synthetic or natural fragment of either having a sulfhydryl group thereon by treatment thereof with an activator of the structure ##STR16## where X represents a non-reacting group comprising substituted or unsubstituted phenyl or C 1-10 alkylene moieties, or a combination thereof, or an amino acid chain, so as to cause reaction of the maleiimide group of the activator with a said sulfhydryl group on said hormone, peptide or fragment and so as to minimize reaction of the active ester group with any amino group present on said hormone, peptide or fragment; and treating the resulting activated hormone, peptide or fragment at slightly alkaline pH with a carrier moiety biologically foreign to said animal and selected having a size sufficient to elicit antibody response following the administration thereof into the body of said animal.
Claim 3
Dependent Claim
11 words
A process according to claim 1 wherein said polypeptide is: Thr-Cys-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln.
Claim 4
Dependent Claim
12 words
A process according to claim 2 wherein said carrier is diphtheria toxoid.
Claim 5
Dependent Claim
11 words
A process according to claim 1 wherein said polypeptide is Asp-His-Pro-Leu-Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln.
Claim 6
Dependent Claim
12 words
A process according to claim 4 wherein said carrier is diphtheria toxoid.
Claim 7
Dependent Claim
25 words
A process according to claim 4 wherein said polypeptide has the SH group on its non-terminal cysteine and the amino group on its lysine blocked.
Claim 8
Dependent Claim
19 words
A process according to claim 6 wherein said blocking of said SH group is effected with an acetamidomethyl group.
Claim 9
Dependent Claim
11 words
A process according to claim 1 wherein said polypeptide is Cys-Asp-His-Pro-Leu-Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln.
Claim 10
Dependent Claim
12 words
A process according to claim 8 wherein said carrier is diphtheria toxoid.
Claim 11
Dependent Claim
18 words
A process according to claim 8 wherein said polypeptide has the SH group on its non-terminal cysteine blocked.
Claim 12
Dependent Claim
19 words
A process according to claim 10 wherein said blocking of said SH group is effected with an acetamidomethyl group.